Literature DB >> 19344787

Hepatitis B seroprevalence and disease characteristics in an urban Chinatown community.

Scott J Cotler1, Manish K Dhamija, Fabiolla Siqueira, Anna H Bartram, Brian J Luc, Thomas J Layden, Shirley S Wong.   

Abstract

BACKGROUND & AIMS: Chronic HBV infection is prevalent among Asian immigrants and is an important cause of cirrhosis and hepatocellular carcinoma. The aim of this study was to evaluate the HBsAg seroprevalence and to characterize hepatitis B in persons who presented to an urban Chinatown internal medicine practice.
METHODS: Records were reviewed retrospectively from 4671 adult patients who had at least 1 office visit during a 2-year period. Demographic information and laboratory data were collected. An elevated ALT level was defined as >19 IU/mL for women and >30 IU/mL for men.
RESULTS: All patients were ethnically Chinese, and 97% were born in Asia. HBsAg testing was available in 64% (3012/4671) of cases. The HBsAg seroprevalence rate was 11.1% (335/3012) overall and 14.9% in persons aged 30-39 years. HBeAg testing was available for 75% (250/335) of HBsAg+ cases. Seventy-five percent (188/250) were HBeAg-. Sixty percent (26/43) of HBeAg+ patients with available data had HBV DNA >10(5) copies/mL and an elevated ALT level. Sixteen percent (21/128) of HBeAg- patients with available data had HBV DNA >10(4) copies/mL and an elevated ALT level.
CONCLUSIONS: The HBsAg seroprevalence was high (11.1%) in Chinese immigrants presenting for general medical care. A majority (75%) of HBsAg+ patients were HBeAg-. Sixty percent of HBeAg+ cases and 16% of HBeAg- patients with available data had both HBV DNA and ALT levels that would prompt consideration of antiviral therapy. These findings highlight the importance of testing and medical management of hepatitis B in Chinese Americans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19344787     DOI: 10.1016/j.cgh.2009.03.023

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  5 in total

1.  Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions.

Authors:  David W Hutton; Margaret L Brandeau; Samuel K So
Journal:  Interfaces (Providence)       Date:  2011-05       Impact factor: 1.434

2.  Prevalence, risk factors, and disease knowledge of chronic hepatitis B infection in Vietnamese Americans in California.

Authors:  Nghi B Ha; Huy N Trinh; Trang T Nguyen; Truong-Sinh Leduc; Christopher Bui; Nghiem B Ha; Carrie R Wong; Anh Thu Tran; Mindie H Nguyen
Journal:  J Cancer Educ       Date:  2013-06       Impact factor: 2.037

3.  Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic.

Authors:  R G Gish; S L Cooper
Journal:  J Viral Hepat       Date:  2010-12-08       Impact factor: 3.728

4.  The Seroprevalence of Hepatitis B in Akbar Abad Village, Kavar, Southern Iran.

Authors:  Mohammad Reza Fattahi; Davood Mehrabani; Sara Mehvarz; Najmeh Zarei Jaliani; Abbas Alipour; Mohammad Ali Davarpanah
Journal:  Int J Prev Med       Date:  2014-12

5.  Estimating the proportion of people with chronic hepatitis B virus infection eligible for hepatitis B antiviral treatment worldwide: a systematic review and meta-analysis.

Authors:  Mingjuan Tan; Ajeet S Bhadoria; Fuqiang Cui; Alex Tan; Judith Van Holten; Philippa Easterbrook; Nathan Ford; Qin Han; Ying Lu; Marc Bulterys; Yvan Hutin
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-11-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.